Page last updated: 2024-08-25

efaroxan and Compensatory Hyperinsulinemia

efaroxan has been researched along with Compensatory Hyperinsulinemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antoine, MH; Aynsley-Green, A; Barnes, PD; Clayton, P; Cosgrove, KE; De Lonlay, P; de Tullio, P; Dunne, MJ; Hussain, K; Lebrun, P; Lee, AT; Lindley, KJ; McCloy, R; Nihoul-Fékété, C; Pirotte, B; Rahier, J; Robert, JJ; Saudubray, JM1

Other Studies

1 other study(ies) available for efaroxan and Compensatory Hyperinsulinemia

ArticleYear
BPDZ 154 activates adenosine 5'-triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism.
    The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:11

    Topics: Adenosine Triphosphate; Adolescent; Adrenergic alpha-Antagonists; Animals; Benzofurans; Benzothiadiazines; Calcium Radioisotopes; Cell Line; Child, Preschool; Cyclic S-Oxides; Female; Glucose; Humans; Hyperinsulinism; Hypoglycemic Agents; Imidazoles; Infant; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Male; Pancreatic Neoplasms; Potassium Channels; Rats; Rats, Wistar; Rubidium Radioisotopes; Tolbutamide

2002